$525K R&D Rebate Received
Filed with ASX · · 1 page · English
Summary by 6ix AI
Biotron Limited has announced the receipt of an R&D Tax Incentive rebate for its research and development activities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Biotron
- Hepatitis B Virus Program Update
- Half Yearly Report and Accounts
- Successful Issue of the Entitlement Offer Shortfall
- Quarterly Activities/Appendix 4C Cash Flow Report
- Security Class Reinstatement to Quotation - BITO
Later from Biotron
- Sedarex First Milestone Met
- HBV Treatment to Progress Towards Human Trials
- Change in substantial holding
- Full Year Statutory Accounts and Appendix 4E
- Corporate Governance Statement
Follow Biotron into a list and get an email when it puts out news.
Follow Biotron